AstraZeneca admits its Covid vaccine can cause rare side effect in court documents for first time The Telegraph - 28 Apr 2024 AstraZeneca admits its Covid vaccine can cause rare side effect in court documents for first time ... More
Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection Nature.com - 26 Feb 2024 Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection ... More
Safe COVID-19 vaccines for Europeans - Europäische Kommission European Union - 25 Aug 2023 Safe COVID-19 vaccines for Europeans - Europäische Kommission ... More
Further developed COVID vaccine from MedUni Vienna shows promising results against Omikron MedUni Wien - 11 Mar 2024 Further developed COVID vaccine from MedUni Vienna shows promising results against Omikron ... More
JN1 als Basis für angepasste Covid-19-Impfstoffe Pharmazeutische Zeitung - 29 Apr 2024 JN1 als Basis für angepasste Covid-19-Impfstoffe ... More
The Novavax vaccine against COVID-19: What you need to know World Health Organization (WHO) - 28 Sep 2022 The Novavax vaccine against COVID-19: What you need to know ... More
Coronavirus (COVID-19) Vaccinations Our World in Data - 16 Dec 2020 Coronavirus (COVID-19) Vaccinations ... More
NIH clinical trial of investigational vaccine for COVID-19 begins National Institutes of Health (NIH) (.gov) - 16 Mar 2020 NIH clinical trial of investigational vaccine for COVID-19 begins ... More
More Than 12.7 Billion Shots Given: Covid-19 Tracker Bloomberg - 06 Oct 2022 More Than 12.7 Billion Shots Given: Covid-19 Tracker ... More
Studie zu neuem mRNA-Impfstoff: Erste Patienten werden gegen Hautkrebs geimpft - n-tv.de n-tv NACHRICHTEN - 29 Apr 2024 Studie zu neuem mRNA-Impfstoff: Erste Patienten werden gegen Hautkrebs geimpft - n-tv.de ... More
Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters Nature.com - 03 Apr 2023 Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters ... More
Weiterentwickelter COVID-Impfstoff der MedUni Wien zeigt vielversprechende Ergebnisse gegen Omikron MedUni Wien - 11 Mar 2024 Weiterentwickelter COVID-Impfstoff der MedUni Wien zeigt vielversprechende Ergebnisse gegen Omikron ... More
Nächster Covid-19-Impfstoff mit drei Vorteilen Pharmazeutische Zeitung - 26 Mar 2024 Nächster Covid-19-Impfstoff mit drei Vorteilen ... More
Sinopharm [Vero Cell]- Inactivated, COVID-19 vaccine World Health Organization (WHO) - 03 Jun 2022 Sinopharm [Vero Cell]- Inactivated, COVID-19 vaccine ... More
Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine Nature.com - 04 Jul 2022 Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine ... More
COVID-19: Dritter angepasster Impfstoff für Impfung in der EU zugelassen European Union - 01 Nov 2023 COVID-19: Dritter angepasster Impfstoff für Impfung in der EU zugelassen ... More
EMA starts second rolling review of a COVID-19 vaccine | European Medicines Agency European Medicines Agency | - 06 Oct 2020 EMA starts second rolling review of a COVID-19 vaccine | European Medicines Agency ... More